| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |